

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.10374655 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.01782325 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.63509004 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63509004 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.31713825 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31713825 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 7.01005272 |
| 8 | oxidative demethylation (GO:0070989) | 6.64422630 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.43986907 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.43986907 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.43986907 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.15338052 |
| 13 | glyoxylate metabolic process (GO:0046487) | 6.13419098 |
| 14 | drug metabolic process (GO:0017144) | 6.12394551 |
| 15 | tryptophan metabolic process (GO:0006568) | 6.06127412 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91679183 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.90899618 |
| 18 | cysteine metabolic process (GO:0006534) | 5.75512532 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 5.70542312 |
| 20 | urea cycle (GO:0000050) | 5.50914637 |
| 21 | urea metabolic process (GO:0019627) | 5.50914637 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45146982 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.38249954 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.33294363 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.24156983 |
| 26 | lysine metabolic process (GO:0006553) | 5.22077269 |
| 27 | lysine catabolic process (GO:0006554) | 5.22077269 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 5.18669588 |
| 29 | S-adenosylmethionine metabolic process (GO:0046500) | 5.16365672 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.16189673 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 5.10088508 |
| 32 | homocysteine metabolic process (GO:0050667) | 5.09301226 |
| 33 | protein carboxylation (GO:0018214) | 5.09067256 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09067256 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 5.08314779 |
| 36 | regulation of fibrinolysis (GO:0051917) | 5.06322582 |
| 37 | complement activation, alternative pathway (GO:0006957) | 5.01839449 |
| 38 | bile acid metabolic process (GO:0008206) | 5.01580851 |
| 39 | regulation of protein activation cascade (GO:2000257) | 4.97946580 |
| 40 | alkaloid metabolic process (GO:0009820) | 4.93731138 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.83070555 |
| 42 | ethanol metabolic process (GO:0006067) | 4.81901062 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.78035207 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.77559298 |
| 45 | regulation of plasminogen activation (GO:0010755) | 4.72086120 |
| 46 | regulation of complement activation (GO:0030449) | 4.64966296 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.62080734 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.56994261 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.55211132 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 4.53219012 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.52377219 |
| 52 | protein activation cascade (GO:0072376) | 4.46176875 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46108827 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.46108827 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.46108827 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.45742275 |
| 57 | amine catabolic process (GO:0009310) | 4.45742275 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.42842322 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 4.42285672 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.41708245 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.41708245 |
| 62 | glutamate metabolic process (GO:0006536) | 4.40719433 |
| 63 | triglyceride homeostasis (GO:0070328) | 4.40586728 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.40586728 |
| 65 | glycine metabolic process (GO:0006544) | 4.37935302 |
| 66 | coenzyme catabolic process (GO:0009109) | 4.35739796 |
| 67 | drug catabolic process (GO:0042737) | 4.33987028 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.30839697 |
| 69 | cellular glucuronidation (GO:0052695) | 4.30154680 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.26238227 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.25674658 |
| 72 | urate metabolic process (GO:0046415) | 4.25561353 |
| 73 | phospholipid efflux (GO:0033700) | 4.23690942 |
| 74 | drug transmembrane transport (GO:0006855) | 4.20715108 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.20239831 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 4.18362447 |
| 77 | regulation of humoral immune response (GO:0002920) | 4.15989897 |
| 78 | negative regulation of hemostasis (GO:1900047) | 4.15376557 |
| 79 | negative regulation of blood coagulation (GO:0030195) | 4.15376557 |
| 80 | complement activation (GO:0006956) | 4.15095789 |
| 81 | ethanol oxidation (GO:0006069) | 4.08170934 |
| 82 | aldehyde catabolic process (GO:0046185) | 4.08169041 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 4.08028304 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06143522 |
| 85 | complement activation, classical pathway (GO:0006958) | 4.03779271 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 4.01323981 |
| 87 | ketone body metabolic process (GO:1902224) | 3.99806973 |
| 88 | negative regulation of protein activation cascade (GO:2000258) | 3.96433844 |
| 89 | arginine metabolic process (GO:0006525) | 3.96432875 |
| 90 | acute-phase response (GO:0006953) | 3.95875582 |
| 91 | cholesterol efflux (GO:0033344) | 3.90986423 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.89183135 |
| 93 | organic acid catabolic process (GO:0016054) | 3.89183135 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.89106887 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.88808025 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.88808025 |
| 97 | cytolysis (GO:0019835) | 3.87593467 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.85329013 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.84364004 |
| 100 | opsonization (GO:0008228) | 3.82445404 |
| 101 | fibrinolysis (GO:0042730) | 3.81135120 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.79307626 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78902264 |
| 104 | negative regulation of coagulation (GO:0050819) | 3.73937697 |
| 105 | negative regulation of wound healing (GO:0061045) | 3.73880007 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.72893044 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70489242 |
| 108 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.70437740 |
| 109 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.69023718 |
| 110 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.69023718 |
| 111 | cofactor catabolic process (GO:0051187) | 3.68540060 |
| 112 | L-methionine salvage (GO:0071267) | 3.67832459 |
| 113 | L-methionine biosynthetic process (GO:0071265) | 3.67832459 |
| 114 | amino acid salvage (GO:0043102) | 3.67832459 |
| 115 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67610683 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.63687553 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.62496384 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61236026 |
| 119 | hormone catabolic process (GO:0042447) | 3.60754958 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.60606214 |
| 121 | heme transport (GO:0015886) | 3.60160317 |
| 122 | monocarboxylic acid catabolic process (GO:0072329) | 3.58831266 |
| 123 | fatty acid oxidation (GO:0019395) | 3.58785503 |
| 124 | NAD biosynthetic process (GO:0009435) | 3.58513483 |
| 125 | carnitine metabolic process (GO:0009437) | 3.57706850 |
| 126 | fatty acid beta-oxidation (GO:0006635) | 3.57613779 |
| 127 | sterol homeostasis (GO:0055092) | 3.56371854 |
| 128 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56184233 |
| 129 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56184233 |
| 130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55369450 |
| 131 | steroid catabolic process (GO:0006706) | 3.52776663 |
| 132 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.52650237 |
| 133 | xenobiotic metabolic process (GO:0006805) | 3.51395330 |
| 134 | positive regulation of blood coagulation (GO:0030194) | 3.50605081 |
| 135 | positive regulation of hemostasis (GO:1900048) | 3.50605081 |
| 136 | sodium-independent organic anion transport (GO:0043252) | 3.47545379 |
| 137 | intestinal cholesterol absorption (GO:0030299) | 3.44812086 |
| 138 | negative regulation of lipase activity (GO:0060192) | 3.42119335 |
| 139 | arginine catabolic process (GO:0006527) | 3.39832240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36823000 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14576081 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.91105113 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44666869 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.18607610 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.94290910 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75830185 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98325546 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97809554 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50909274 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17103095 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11911900 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11673856 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08304979 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01343458 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8068221 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96956113 |
| 18 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79754754 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72899712 |
| 20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.70304142 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67328903 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61409939 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60941271 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53123661 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48847821 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47447196 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44801463 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43217306 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42372932 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41341544 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38976258 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34781971 |
| 33 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34664242 |
| 34 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33446546 |
| 35 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.33446546 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31512774 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26100379 |
| 38 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25597938 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23586256 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20176507 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19641852 |
| 42 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19131559 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18767813 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18321469 |
| 45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18321469 |
| 46 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17198580 |
| 47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16634388 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15826359 |
| 49 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15756620 |
| 50 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14644594 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13867981 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12017947 |
| 53 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.09534164 |
| 54 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.08948772 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08410565 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08410565 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07741297 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07048280 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04096733 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04060242 |
| 61 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.03149073 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01016660 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00702219 |
| 64 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00258163 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99713253 |
| 66 | NFYA_21822215_ChIP-Seq_K562_Human | 0.99105075 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98705826 |
| 68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98554655 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98201163 |
| 70 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97850651 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97359032 |
| 72 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97111250 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96868828 |
| 74 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96356679 |
| 75 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95613424 |
| 76 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95480008 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95341762 |
| 78 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95200060 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94469992 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94203180 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94028810 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93374539 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93047000 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92686396 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92395120 |
| 86 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92374026 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91082352 |
| 88 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.90869048 |
| 89 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90469702 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90381953 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90170950 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90047030 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.89944283 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88749592 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88156448 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88129150 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88087064 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87418671 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86014752 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85970466 |
| 101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82528548 |
| 102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81519076 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78540685 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78149560 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75993745 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71745460 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71122531 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70736030 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70325214 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69448263 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69405510 |
| 112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68874700 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67202775 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66545483 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64676882 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64266043 |
| 117 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63622258 |
| 118 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63622258 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63389373 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62748449 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60495033 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60306752 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59019691 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58218678 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58140793 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.55876054 |
| 127 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55297039 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55040577 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54855266 |
| 130 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54227701 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53628770 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53006751 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52184919 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51466034 |
| 135 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50965229 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.50181071 |
| 137 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.49642198 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48266740 |
| 139 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47228003 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46501523 |
| 141 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.45840361 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45475912 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45175130 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43681186 |
| 145 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43528130 |
| 146 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43020781 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42540003 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42337701 |
| 149 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41762869 |
| 150 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41620089 |
| 151 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41413258 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41219810 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.40850151 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40628602 |
| 155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40508234 |
| 156 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40213108 |
| 157 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40099568 |
| 158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39690390 |
| 159 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.39503995 |
| 160 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.38475636 |
| 161 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38399029 |
| 162 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38368804 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.37502170 |
| 164 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37149100 |
| 165 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36796204 |
| 166 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35503497 |
| 167 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.34598125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25089373 |
| 2 | MP0005360_urolithiasis | 7.91241404 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27295730 |
| 4 | MP0005365_abnormal_bile_salt | 6.02809956 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09877372 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07391473 |
| 7 | MP0003252_abnormal_bile_duct | 3.93614959 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.40022647 |
| 9 | MP0005332_abnormal_amino_acid | 3.13057394 |
| 10 | MP0003195_calcinosis | 3.10541701 |
| 11 | MP0009840_abnormal_foam_cell | 2.95689799 |
| 12 | MP0005083_abnormal_biliary_tract | 2.85054645 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.56184961 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.51264726 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.29100398 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.22715248 |
| 17 | MP0000609_abnormal_liver_physiology | 2.07132982 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.04083985 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84777786 |
| 20 | MP0003868_abnormal_feces_composition | 1.80533798 |
| 21 | MP0001764_abnormal_homeostasis | 1.70636849 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63375723 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.56881474 |
| 24 | MP0005451_abnormal_body_composition | 1.51270884 |
| 25 | MP0002736_abnormal_nociception_after | 1.45862090 |
| 26 | MP0009697_abnormal_copulation | 1.45580916 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.44325564 |
| 28 | MP0003186_abnormal_redox_activity | 1.38564787 |
| 29 | MP0003011_delayed_dark_adaptation | 1.25301845 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.22288364 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.19911925 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.18968821 |
| 33 | MP0000598_abnormal_liver_morphology | 1.14433923 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.13111730 |
| 35 | MP0009764_decreased_sensitivity_to | 1.09046030 |
| 36 | MP0005647_abnormal_sex_gland | 1.08566156 |
| 37 | MP0003646_muscle_fatigue | 1.02665417 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 0.99031735 |
| 39 | MP0000604_amyloidosis | 0.95975908 |
| 40 | MP0009763_increased_sensitivity_to | 0.94718903 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 0.93960239 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 0.92774044 |
| 43 | MP0002876_abnormal_thyroid_physiology | 0.92436902 |
| 44 | MP0004142_abnormal_muscle_tone | 0.89927839 |
| 45 | MP0008469_abnormal_protein_level | 0.89815586 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.89466466 |
| 47 | MP0009642_abnormal_blood_homeostasis | 0.89391151 |
| 48 | MP0001756_abnormal_urination | 0.87648621 |
| 49 | MP0002254_reproductive_system_inflammat | 0.87409945 |
| 50 | MP0005670_abnormal_white_adipose | 0.85430314 |
| 51 | MP0009745_abnormal_behavioral_response | 0.84135113 |
| 52 | MP0005187_abnormal_penis_morphology | 0.83707845 |
| 53 | MP0005408_hypopigmentation | 0.83558486 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.81628296 |
| 55 | MP0004043_abnormal_pH_regulation | 0.79022928 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.76840997 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.76098461 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.75387965 |
| 59 | MP0002136_abnormal_kidney_physiology | 0.74624230 |
| 60 | MP0005535_abnormal_body_temperature | 0.74139684 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.73904446 |
| 62 | MP0001529_abnormal_vocalization | 0.73437558 |
| 63 | MP0001661_extended_life_span | 0.73378301 |
| 64 | MP0002971_abnormal_brown_adipose | 0.68229466 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.67046064 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 0.65314143 |
| 67 | MP0005334_abnormal_fat_pad | 0.64812655 |
| 68 | MP0004924_abnormal_behavior | 0.64130555 |
| 69 | MP0005386_behavior/neurological_phenoty | 0.64130555 |
| 70 | MP0001984_abnormal_olfaction | 0.63787755 |
| 71 | MP0003690_abnormal_glial_cell | 0.61612154 |
| 72 | MP0002132_abnormal_respiratory_system | 0.60863630 |
| 73 | MP0006292_abnormal_olfactory_placode | 0.60697684 |
| 74 | MP0002272_abnormal_nervous_system | 0.60046792 |
| 75 | MP0005266_abnormal_metabolism | 0.59828745 |
| 76 | MP0004130_abnormal_muscle_cell | 0.59214850 |
| 77 | MP0002928_abnormal_bile_duct | 0.58859427 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.58420530 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.57860677 |
| 80 | MP0009053_abnormal_anal_canal | 0.57522891 |
| 81 | MP0003329_amyloid_beta_deposits | 0.55047776 |
| 82 | MP0005646_abnormal_pituitary_gland | 0.54135338 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.53990075 |
| 84 | MP0005395_other_phenotype | 0.52014643 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.51504845 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.49817285 |
| 87 | MP0004885_abnormal_endolymph | 0.49721141 |
| 88 | MP0003724_increased_susceptibility_to | 0.48452331 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.48433254 |
| 90 | MP0001440_abnormal_grooming_behavior | 0.47981044 |
| 91 | MP0005448_abnormal_energy_balance | 0.47410627 |
| 92 | MP0001501_abnormal_sleep_pattern | 0.47319174 |
| 93 | MP0009785_altered_susceptibility_to | 0.46966257 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.46765712 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.45875447 |
| 96 | MP0002572_abnormal_emotion/affect_behav | 0.45640541 |
| 97 | MP0002102_abnormal_ear_morphology | 0.45486873 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.44901199 |
| 99 | MP0003633_abnormal_nervous_system | 0.44541200 |
| 100 | MP0003879_abnormal_hair_cell | 0.43832281 |
| 101 | MP0008874_decreased_physiological_sensi | 0.43581909 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.43361630 |
| 103 | MP0003718_maternal_effect | 0.43269341 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.43221853 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.43203260 |
| 106 | MP0003953_abnormal_hormone_level | 0.42459063 |
| 107 | MP0002064_seizures | 0.41991781 |
| 108 | MP0002067_abnormal_sensory_capabilities | 0.41183316 |
| 109 | MP0002734_abnormal_mechanical_nocicepti | 0.41175374 |
| 110 | MP0002168_other_aberrant_phenotype | 0.40635751 |
| 111 | MP0003880_abnormal_central_pattern | 0.40178800 |
| 112 | MP0008873_increased_physiological_sensi | 0.40131021 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.39650391 |
| 114 | MP0003878_abnormal_ear_physiology | 0.39575153 |
| 115 | MP0005377_hearing/vestibular/ear_phenot | 0.39575153 |
| 116 | MP0002822_catalepsy | 0.39428237 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.39374955 |
| 118 | MP0003075_altered_response_to | 0.38655650 |
| 119 | MP0005166_decreased_susceptibility_to | 0.38027718 |
| 120 | MP0009046_muscle_twitch | 0.37720873 |
| 121 | MP0003436_decreased_susceptibility_to | 0.37634551 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.37157281 |
| 123 | MP0008872_abnormal_physiological_respon | 0.35900672 |
| 124 | MP0004381_abnormal_hair_follicle | 0.35482197 |
| 125 | MP0009672_abnormal_birth_weight | 0.35202093 |
| 126 | MP0002796_impaired_skin_barrier | 0.33663274 |
| 127 | MP0006082_CNS_inflammation | 0.33330814 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.32093417 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.32030249 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.31526902 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.31211325 |
| 132 | MP0009115_abnormal_fat_cell | 0.30944677 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.30328661 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.29181546 |
| 135 | MP0000249_abnormal_blood_vessel | 0.27624912 |
| 136 | MP0000579_abnormal_nail_morphology | 0.26272991 |
| 137 | MP0001853_heart_inflammation | 0.25884325 |
| 138 | MP0002970_abnormal_white_adipose | 0.25523848 |
| 139 | MP0004883_abnormal_blood_vessel | 0.24054516 |
| 140 | MP0003959_abnormal_lean_body | 0.22774862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.24380192 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.99305235 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.85358595 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37018789 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.09128213 |
| 6 | Xanthomatosis (HP:0000991) | 6.03335622 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.91652751 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.15531557 |
| 9 | Complement deficiency (HP:0004431) | 4.91368126 |
| 10 | Hyperammonemia (HP:0001987) | 4.66481002 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65470083 |
| 12 | Joint hemorrhage (HP:0005261) | 4.62256822 |
| 13 | Hyperglycinemia (HP:0002154) | 4.58835597 |
| 14 | Ketosis (HP:0001946) | 4.48163580 |
| 15 | Hyperglycinuria (HP:0003108) | 4.45881441 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.40399444 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.35022363 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.33429377 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.30173304 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30173304 |
| 21 | Epidermoid cyst (HP:0200040) | 4.24690939 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09733228 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.09468953 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.03532222 |
| 25 | Fat malabsorption (HP:0002630) | 3.97350931 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.83756259 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80091624 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.74784243 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63414135 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61100681 |
| 31 | Abnormality of complement system (HP:0005339) | 3.54737574 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46911404 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.40841290 |
| 34 | Ketoacidosis (HP:0001993) | 3.40086307 |
| 35 | Gout (HP:0001997) | 3.37605063 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.36006801 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.34477656 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30283299 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.26277015 |
| 40 | Fair hair (HP:0002286) | 3.21830021 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.21216123 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.17217576 |
| 43 | Nephritis (HP:0000123) | 3.08541510 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.00263541 |
| 45 | Steatorrhea (HP:0002570) | 2.98186627 |
| 46 | Metabolic acidosis (HP:0001942) | 2.96270826 |
| 47 | Vascular calcification (HP:0004934) | 2.82986945 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78500214 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.78500214 |
| 50 | Lethargy (HP:0001254) | 2.74857887 |
| 51 | Spontaneous abortion (HP:0005268) | 2.72265700 |
| 52 | Myocardial infarction (HP:0001658) | 2.71799240 |
| 53 | Osteomalacia (HP:0002749) | 2.70670358 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.70381006 |
| 55 | Bile duct proliferation (HP:0001408) | 2.65239636 |
| 56 | Abnormal biliary tract physiology (HP:0012439) | 2.65239636 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.63989649 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.60390479 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.59997446 |
| 60 | Skin nodule (HP:0200036) | 2.54661789 |
| 61 | Alkalosis (HP:0001948) | 2.51507741 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.49610902 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.47911467 |
| 64 | Cerebral edema (HP:0002181) | 2.45584756 |
| 65 | Spastic diplegia (HP:0001264) | 2.45005660 |
| 66 | Irritability (HP:0000737) | 2.44786181 |
| 67 | Malnutrition (HP:0004395) | 2.43794787 |
| 68 | Neonatal onset (HP:0003623) | 2.42829752 |
| 69 | Pulmonary embolism (HP:0002204) | 2.41394637 |
| 70 | Enlarged kidneys (HP:0000105) | 2.38157547 |
| 71 | Increased purine levels (HP:0004368) | 2.38095450 |
| 72 | Hyperuricemia (HP:0002149) | 2.38095450 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.33532819 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.32737743 |
| 75 | Acanthocytosis (HP:0001927) | 2.32144350 |
| 76 | Mitral stenosis (HP:0001718) | 2.31924729 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 2.29767597 |
| 78 | Vomiting (HP:0002013) | 2.29657667 |
| 79 | Glomerulonephritis (HP:0000099) | 2.28834708 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.24595035 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.22982859 |
| 82 | Rickets (HP:0002748) | 2.22873574 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.19781697 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.19781697 |
| 85 | Pancreatitis (HP:0001733) | 2.18959757 |
| 86 | Hyperventilation (HP:0002883) | 2.18254706 |
| 87 | Cholelithiasis (HP:0001081) | 2.17682265 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16277787 |
| 89 | Late onset (HP:0003584) | 2.15559937 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.13250816 |
| 91 | Glycosuria (HP:0003076) | 2.13250816 |
| 92 | Arthropathy (HP:0003040) | 2.10517502 |
| 93 | Cholecystitis (HP:0001082) | 2.09912069 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.09912069 |
| 95 | Neonatal hypoglycemia (HP:0001998) | 2.09592420 |
| 96 | Esophageal varix (HP:0002040) | 2.07292162 |
| 97 | Amyloidosis (HP:0011034) | 2.05727381 |
| 98 | Menorrhagia (HP:0000132) | 2.05559665 |
| 99 | Opisthotonus (HP:0002179) | 2.05207922 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.04023940 |
| 101 | Brushfield spots (HP:0001088) | 2.03768326 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.03681062 |
| 103 | Hyperalaninemia (HP:0003348) | 2.03681062 |
| 104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03681062 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 2.01513774 |
| 106 | Thrombophlebitis (HP:0004418) | 2.00912100 |
| 107 | Gingival bleeding (HP:0000225) | 1.98096728 |
| 108 | Renal cortical cysts (HP:0000803) | 1.96302649 |
| 109 | Abnormal urine phosphate concentration (HP:0012599) | 1.95979955 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.95604272 |
| 111 | Gangrene (HP:0100758) | 1.93915883 |
| 112 | Hypothermia (HP:0002045) | 1.88180938 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 1.86955219 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.85163299 |
| 115 | Joint swelling (HP:0001386) | 1.84422609 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83933875 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.82792306 |
| 118 | Elevated hepatic transaminases (HP:0002910) | 1.81675206 |
| 119 | Poikilocytosis (HP:0004447) | 1.80594418 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80590474 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79713858 |
| 122 | Blue irides (HP:0000635) | 1.76906845 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.70518994 |
| 124 | Dyskinesia (HP:0100660) | 1.64582043 |
| 125 | Cerebral palsy (HP:0100021) | 1.64462070 |
| 126 | Retinal atrophy (HP:0001105) | 1.64335271 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.63687410 |
| 128 | Potter facies (HP:0002009) | 1.61262148 |
| 129 | Facial shape deformation (HP:0011334) | 1.61262148 |
| 130 | Abnormality of the renal cortex (HP:0011035) | 1.56843806 |
| 131 | Pancreatic cysts (HP:0001737) | 1.53407529 |
| 132 | Increased serum ferritin (HP:0003281) | 1.52546824 |
| 133 | Thyroiditis (HP:0100646) | 1.52392431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28458735 |
| 2 | FGFR4 | 4.37049441 |
| 3 | SIK1 | 4.23906804 |
| 4 | ERN1 | 3.90586828 |
| 5 | INSRR | 3.13353379 |
| 6 | ZAK | 2.92956854 |
| 7 | TAOK3 | 2.84047830 |
| 8 | MAPK13 | 2.79270181 |
| 9 | MAP4K2 | 2.76010895 |
| 10 | ERBB4 | 2.68894525 |
| 11 | CASK | 2.66003901 |
| 12 | ADRBK2 | 2.57899461 |
| 13 | BMPR1B | 2.28637778 |
| 14 | MST1R | 2.20305882 |
| 15 | MARK1 | 2.14978950 |
| 16 | MAP2K4 | 2.13282406 |
| 17 | TLK1 | 2.08492856 |
| 18 | WNK3 | 1.95275526 |
| 19 | MAPK11 | 1.90299971 |
| 20 | NTRK3 | 1.88683782 |
| 21 | TXK | 1.84023938 |
| 22 | MAP3K4 | 1.83509431 |
| 23 | MUSK | 1.82017320 |
| 24 | PKN2 | 1.76473693 |
| 25 | PIK3CG | 1.74432762 |
| 26 | WNK4 | 1.74279203 |
| 27 | FLT3 | 1.70683474 |
| 28 | TYK2 | 1.57445556 |
| 29 | STK38L | 1.56024026 |
| 30 | LATS1 | 1.53105251 |
| 31 | ACVR1B | 1.52907249 |
| 32 | NUAK1 | 1.50560371 |
| 33 | ABL2 | 1.47696456 |
| 34 | PHKG1 | 1.46889372 |
| 35 | PHKG2 | 1.46889372 |
| 36 | OXSR1 | 1.46722322 |
| 37 | PINK1 | 1.38055881 |
| 38 | CAMKK2 | 1.37156140 |
| 39 | FRK | 1.36123857 |
| 40 | DAPK2 | 1.35888918 |
| 41 | NEK9 | 1.35567047 |
| 42 | DYRK2 | 1.33189263 |
| 43 | PTK6 | 1.32839296 |
| 44 | MAP3K7 | 1.31077691 |
| 45 | TRIB3 | 1.30977869 |
| 46 | BCR | 1.27482715 |
| 47 | MAP3K14 | 1.21354760 |
| 48 | MAP2K7 | 1.20330845 |
| 49 | TNIK | 1.20100607 |
| 50 | PIK3CA | 1.19338654 |
| 51 | PRKAA2 | 1.18219913 |
| 52 | OBSCN | 1.18114285 |
| 53 | GRK6 | 1.15921071 |
| 54 | FGFR2 | 1.13749159 |
| 55 | KDR | 1.12863151 |
| 56 | JAK2 | 1.12665322 |
| 57 | MAP2K3 | 1.03768100 |
| 58 | PRKCE | 1.01341820 |
| 59 | TIE1 | 0.99664068 |
| 60 | MAPK15 | 0.99586163 |
| 61 | TBK1 | 0.94876138 |
| 62 | MAPK4 | 0.93240201 |
| 63 | SGK3 | 0.93114487 |
| 64 | ERBB2 | 0.92761292 |
| 65 | PRKCZ | 0.91515249 |
| 66 | JAK1 | 0.88660857 |
| 67 | SGK2 | 0.86656654 |
| 68 | SGK223 | 0.86257172 |
| 69 | SGK494 | 0.86257172 |
| 70 | TNK2 | 0.85875934 |
| 71 | MAP3K3 | 0.85433894 |
| 72 | VRK1 | 0.83845901 |
| 73 | IRAK3 | 0.82844757 |
| 74 | PRKACA | 0.81907180 |
| 75 | EPHB1 | 0.81664942 |
| 76 | MAPK12 | 0.79233958 |
| 77 | PAK3 | 0.78393492 |
| 78 | ADRBK1 | 0.77569880 |
| 79 | GSK3A | 0.77525170 |
| 80 | CDK8 | 0.76757168 |
| 81 | MAP3K10 | 0.75609409 |
| 82 | NLK | 0.75053243 |
| 83 | PRKAA1 | 0.74907051 |
| 84 | TGFBR2 | 0.74644383 |
| 85 | DYRK1B | 0.74464552 |
| 86 | MET | 0.74326041 |
| 87 | PRKACG | 0.72996288 |
| 88 | DYRK1A | 0.71662190 |
| 89 | BRSK2 | 0.69411405 |
| 90 | PRKG1 | 0.68919957 |
| 91 | CDK6 | 0.68450740 |
| 92 | CSK | 0.67030000 |
| 93 | CSNK1D | 0.66570576 |
| 94 | MAP3K11 | 0.63842512 |
| 95 | MAP2K6 | 0.63302682 |
| 96 | MAP4K1 | 0.62093606 |
| 97 | IKBKB | 0.62027969 |
| 98 | CAMK2G | 0.60399688 |
| 99 | CSNK1G3 | 0.58831393 |
| 100 | PDK4 | 0.58787057 |
| 101 | PDK3 | 0.58787057 |
| 102 | NTRK2 | 0.56671904 |
| 103 | CSNK1A1 | 0.56031250 |
| 104 | MAP2K2 | 0.55945277 |
| 105 | MAPK7 | 0.55757815 |
| 106 | EPHA3 | 0.55749379 |
| 107 | IKBKE | 0.54987350 |
| 108 | CSF1R | 0.54583251 |
| 109 | PTK2 | 0.53969811 |
| 110 | TRIM28 | 0.52710512 |
| 111 | PRKCQ | 0.52699263 |
| 112 | PDPK1 | 0.52569845 |
| 113 | ERBB3 | 0.52088662 |
| 114 | SYK | 0.51230490 |
| 115 | SGK1 | 0.50885567 |
| 116 | GRK1 | 0.50668347 |
| 117 | TEC | 0.48822583 |
| 118 | CAMK2A | 0.48265474 |
| 119 | CAMK1D | 0.48020567 |
| 120 | RIPK1 | 0.47577407 |
| 121 | FGFR3 | 0.46701206 |
| 122 | CSNK1G1 | 0.46363233 |
| 123 | STK11 | 0.46297332 |
| 124 | EPHA4 | 0.44656830 |
| 125 | RPS6KA5 | 0.43942013 |
| 126 | GRK7 | 0.43819069 |
| 127 | PRKCB | 0.43330565 |
| 128 | IGF1R | 0.42912827 |
| 129 | SIK2 | 0.41915125 |
| 130 | MAP3K13 | 0.41806655 |
| 131 | TAOK2 | 0.40452216 |
| 132 | EIF2AK2 | 0.39531464 |
| 133 | IRAK1 | 0.39249157 |
| 134 | MAPKAPK3 | 0.38869936 |
| 135 | CSNK1A1L | 0.38519533 |
| 136 | TGFBR1 | 0.38478189 |
| 137 | IRAK2 | 0.38412068 |
| 138 | MAP3K6 | 0.37921788 |
| 139 | RPS6KA3 | 0.37285901 |
| 140 | PRKACB | 0.37202577 |
| 141 | PRKCG | 0.36837241 |
| 142 | PKN1 | 0.35211935 |
| 143 | MAP3K5 | 0.34949409 |
| 144 | PDK2 | 0.34434165 |
| 145 | PDK1 | 0.32861598 |
| 146 | STK38 | 0.31140894 |
| 147 | CAMK4 | 0.31069060 |
| 148 | CDK4 | 0.31042270 |
| 149 | PBK | 0.30400597 |
| 150 | MAP2K1 | 0.27468385 |
| 151 | PRKCA | 0.27154150 |
| 152 | EGFR | 0.26054434 |
| 153 | MTOR | 0.24481919 |
| 154 | STK39 | 0.23853943 |
| 155 | NEK1 | 0.21716041 |
| 156 | RET | 0.21499248 |
| 157 | KIT | 0.21314829 |
| 158 | CSNK1G2 | 0.21303141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33759608 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43790711 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40191394 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29206254 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95726857 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74240391 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73370713 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66317267 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56157572 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55394767 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53427712 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51675811 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39904980 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35610273 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.20455584 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09222880 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07336264 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88539942 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87782858 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87009073 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84643667 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84512843 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84408984 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83603493 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80001964 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70577360 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68636236 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67630132 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65110115 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64729993 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59877014 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57878833 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57362108 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53743535 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.52955075 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47447878 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40716127 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38127715 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36769344 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31286501 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30097408 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29304666 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29277247 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22162212 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21372949 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19240554 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17653938 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.14975306 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13900477 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07753455 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03181205 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03152454 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02529918 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97875053 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94416755 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90179445 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.89527293 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87219308 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82103914 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74724097 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72789293 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72217534 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70338750 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62455492 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56828228 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48501010 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43878030 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29110485 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28289970 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27419452 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.25004534 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23872327 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23570196 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22513675 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.20442288 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19440757 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19407761 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17999935 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15506947 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14922326 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.13670328 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.12578551 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.12476748 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10956517 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10826704 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06923951 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00111612 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2495228 |
| 89 | Lysosome_Homo sapiens_hsa04142 | -0.2204256 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2163313 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2009675 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1992759 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1904456 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1863815 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1826302 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | -0.1774521 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1653092 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1532132 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1531526 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1389734 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1307725 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1250789 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1186517 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1136712 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1080862 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1033864 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1022139 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0931268 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0919203 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0914853 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0724168 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0491112 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0403011 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | -0.0366019 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0204950 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0171950 |

